ISRCTN83097613
Completed
Not Applicable
Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes Labialis
Klearsen Corporation (USA)0 sites13 target enrollmentSeptember 29, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Klearsen Corporation (USA)
- Enrollment
- 13
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 18 years or greater
- •2\. Peri\-oral HSV occurring four or more times per year
Exclusion Criteria
- •1\. No serious medical illness
- •2\. No use of systemic immunosuppressive therapy
- •3\. No significant dermatological illness on the face
- •4\. No known allergy to metal ions or components of the electrolyte ointment
- •5\. No antiviral therapy in the 7 days prior to an outbreak and during the outbreak
- •6\. Must forego other treatments for HSV during an outbreak
- •7\. Must forego use of lipstick or other emollients to cover a peri\-oral HSV lesion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and safety of iontophoresis in patients with age-related cataractAge-related cataractEye DiseasesSenile cataractISRCTN34571027Zhongshan Ophthalmic Center118
Not yet recruiting
Phase 2
Comparison of efficacy of iontophoresis with glycopyrrolate solution and tap water for palmar/plantar hyperhidrosisCTRI/2022/10/046893MAHARISHI MARKANDESHWAR MEDICAL COLLEGE AND HOSPITA
Completed
Not Applicable
Effect of iontophoresis on the effectiveness of two desensitizing pastes(nano-hydroxyapatite and pro-argin) in treatment of tooth sensitivityHealth Condition 1: K031- Abrasion of teethCTRI/2021/04/032974Dr Anjana Das C45
Active, not recruiting
Phase 2
Treatment for pain reduction and the size of heel spurPLANTAR FASCIITIS CALCIFYINGC04.588.894.797.520RBR-6864tjPUC Minas
Not yet recruiting
Not Applicable
Clinical trial of Iron supplement in anemic pregnant women.Health Condition 1: D509- Iron deficiency anemia, unspecifiedCTRI/2022/11/047376Generex Pharmassist Pvt. Ltd.